Clinical Trials Browser

Phase 1/2 × relatlimab × 90 days × Clear all

Melanoma

NCT05255601 2026-02-25

RELATIVITY-069

Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell

NCT01968109 2026-01-06

An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors

Phase 1/2 Completed

1,482 enrolled 56 charts

Tumor-Agnostic

Neoplasms by Site

NCT03610711 2025-12-22

REACTION

Phase 1/2 Active not recruiting

21 enrolled

Gastrointestinal

Gastroesophageal Cancer

Clinical Trials

Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis

RELATIVITY-069

An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors

REACTION